Homepage

Nyxoah S.A.

NYXH NASDAQ Categories PDF
Healthcare · Medical - Specialties
Mont-Saint-Guibert, WBR 1435, Belgium IPO 2021 nyxoah.com Updated Jun 26, 10:36pm
Price
$1.67
Market Cap
$66.1M
Employees
163
Beta
0.89
Avg Volume
257,230
CEO
Olivier Taelman
Business Description

Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Business History
Price Overview
Last updated: Jun 27, 2026 10:07am (just now)
$1.67
+0.04 (+2.45%)
Day Range
$1.60 – $1.71
52-Week Range
$1.26 – $8.59
50-Day MA
$2.57
200-Day MA
$4.10
Volume
112,134.00
Analyst Price Targets
Low $3.00
Consensus $5.00
High $7.00
(13 analysts)
Share Structure
Outstanding 39,607,235.00
Float 23,635,332.00
Free Float 59.7%
Normal free float — 59.7% of shares trade freely, ~40.3% held by insiders/institutions
Healthy float typical of established companies. Good liquidity for entering and exiting positions without major price impact.
Price History (1 Year)
Last updated: Jun 27, 2026 10:07am (just now)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Last updated: Jun 22, 2026 4:38am (5d ago)
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALC
Stock Price / EPS (Diluted)
-0.70
Stock Price: $1.67
EPS (Diluted): -2.37
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
3.04
Stock Price: $1.67
Total Equity: $49.11M
Shares: 38,107,000
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
-1.05
Market Cap: $66.14M
Total Debt: $41.42M
Cash: $29.99M
EBITDA: -$82.90M
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$161.3M
Market Cap: $66.14M
Total Debt: $41.42M
Cash: $29.99M
P/S Ratio (Price per dollar of revenue)
API
Stock Price / Revenue Per Share
14.89
Stock Price: $1.67
Revenue: $10.02M
Shares: 38,107,000
EV/Sales (Total value vs revenue — works when P/E can't)
API
16.09
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
63.1%
Gross Profit: $6.33M
Revenue: $10.02M
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
-827.8%
Operating Income: -$82.94M
Revenue: $10.02M
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
-899.1%
Net Income: -$90.09M
Revenue: $10.02M
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
-164.4%
Net Income: -$90.09M
Total Equity: $49.11M
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
-116.2%
Operating Income: -$82.94M
Tax Rate: -1.1%
Equity: $49.11M
Total Debt: $41.42M
Cash: $29.99M
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
1.25
Current Assets: $61.19M
Current Liabilities: $48.94M
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
0.84
Short-Term Debt: $23.76M
Long-Term Debt: $17.66M
Total Debt: $41.42M
Total Equity: $49.11M
Rev/Share (Top-line per share)
CALC
Revenue / Shares Outstanding
$0.26
Revenue: $10.02M
Shares: 38,107,000
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$1.29
Total Equity: $49.11M
Shares: 38,107,000
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$-1.79
Operating CF: -$67.50M
CapEx: -$804,698
Shares: 38,107,000
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $1.67
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
Dividends Paid: N/A
Net Income: -$90.09M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares NYXH against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
4h Dividend Discount Model — For dividend/income stocks only
4i Book Value Analysis — For deep value / turnaround stocks only
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 22, 2026 4:38am (5d ago)
Metric 2021 2022 2023 2024 2025
Revenue $852,000 $3.1M $4.3M $4.5M $10.0M
Cost of Revenue $303,000 $1.2M $1.7M $1.6M $3.7M
Gross Profit $549,000 $1.9M $2.7M $3.0M $6.3M
Operating Expenses $26.8M $34.4M $47.8M $61.8M $89.3M
Operating Income -$26.2M -$32.5M -$45.1M -$58.8M -$82.9M
Net Income -$27.6M -$31.2M -$43.2M -$59.2M -$90.1M
EBITDA -$22.6M -$27.9M -$42.1M -$53.8M -$82.9M
EPS $-1.16 $-1.21 $-1.55 $-1.81 $-2.37
EPS (Diluted)
Balance Sheet (Annual)
Last updated: Jun 22, 2026 4:38am (5d ago)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $135.5M $17.9M $21.6M $34.2M $30.0M
Total Current Assets $140.1M $100.3M $68.4M $98.1M $61.2M
Total Assets $170.8M $146.1M $124.2M $158.4M $118.4M
Current Liabilities $11.6M $14.9M $14.4M $21.5M $48.9M
Long-Term Debt $7.8M $8.2M $8.4M $18.7M $17.7M
Total Liabilities $22.2M $25.7M $26.1M $45.2M $69.3M
Total Equity $148.6M $120.3M $98.0M $113.3M $49.1M
Retained Earnings -$87.2M -$118.2M -$160.8M -$217.7M -$305.9M
Cash Flow (Annual)
Last updated: Jun 22, 2026 4:38am (5d ago)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow -$25.3M -$28.8M -$44.8M -$49.2M -$67.5M
Capital Expenditure -$11.8M -$16.3M -$11.0M -$6.1M $-804,698
Free Cash Flow -$37.2M -$45.1M -$55.7M -$55.3M -$68.3M
Acquisitions (net) $0 $0 $0 $0 $2,998
Debt Repayment
Dividends Paid
Stock Buybacks $0 $0 $0 $0 $0
Net Change in Cash $43.2M -$117.6M $3.7M $12.6M $-130,691
Analyst Estimates (Annual)
Last updated: Jun 26, 2026 10:36pm (11h ago)
Metric 2027 2028 2029 2030
Revenue $84.1M
$77.0M – $90.2M
$136.1M
$126.4M – $144.4M
$204.1M
$189.5M – $216.6M
$316.1M
$293.6M – $335.4M
EBITDA -$84.1M
-$90.2M – -$77.0M
-$136.1M
-$144.4M – -$126.4M
-$204.1M
-$216.6M – -$189.5M
-$316.1M
-$335.4M – -$293.6M
Net Income -$34.9M
-$50.8M – -$18.9M
-$15.2M
-$21.0M – -$9.4M
-$2.6M
-$2.8M – -$2.4M
$7.8M
$7.1M – $8.4M
EPS
Growth Trends (YoY %)
Last updated: Jun 22, 2026 4:38am (5d ago)
Metric 2022 2023 2024 2025
Revenue Growth +262.0% +41.0% +4.0% +121.6%
Gross Profit Growth +252.3% +39.2% +10.3% +113.1%
Operating Income Growth -23.8% -38.8% -30.4% -41.0%
Net Income Growth -13.1% -38.4% -37.1% -52.1%
EBITDA Growth -23.4% -50.9% -27.8% -54.2%
Narrative Economics
The story the market is telling about this stock — the intangible X-factor (founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for NYXH — it's generated by the pipeline (market-narrative step).
Community AI Feedback
No community reviews yet for NYXH. Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30